Literature DB >> 11818461

Diagnosis and treatment of venous thromboembolism.

Agnes Y Y Lee1, Jack Hirsh.   

Abstract

The diagnosis of deep vein thrombosis (DVT) and pulmonary embolism (PE) has been improved and simplified over the past decade thanks to advances in noninvasive and readily accessible technology. With high degrees of sensitivity and specificity, venous ultrasonography is favored as the initial investigation for DVT. To diagnose PE, most clinicians rely on diagnostic algorithms that combine clinical assessment, noninvasive lung studies, and, if necessary, venous ultrasonography of the legs and D-dimer testing. Substantial progress has also occurred in the treatment of acute venous thromboembolism with the introduction of low-molecular-weight heparins. This class of antithrombotic agents has changed initial therapy from an inpatient, intravenous regimen that required laborious monitoring to an outpatient practice using weight-adjusted doses of once-daily subcutaneous injections. In addition, several new anticoagulants with theoretical advantages over existing agents have entered phase III studies. Aspects of thrombosis treatment that remain controversial include vena caval interruption and the indications for thrombolysis and surgical thromboembolectomy.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11818461     DOI: 10.1146/annurev.med.53.082901.103957

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  6 in total

Review 1.  [Current controversies in the diagnosis and management of cerebral venous and dural sinus thrombosis].

Authors:  S Schwarz; M Daffertshofer; T Schwarz; D Georgiadis; R W Baumgartner; M Hennerici; C Groden
Journal:  Nervenarzt       Date:  2003-08       Impact factor: 1.214

2.  Myeloid p53 regulates macrophage polarization and venous thrombus resolution by inflammatory vascular remodeling in mice.

Authors:  Subhradip Mukhopadhyay; Toni M Antalis; Khanh P Nguyen; Mark H Hoofnagle; Rajabrata Sarkar
Journal:  Blood       Date:  2017-03-20       Impact factor: 22.113

Review 3.  Ximelagatran/Melagatran: a review of its use in the prevention of venous thromboembolism in orthopaedic surgery.

Authors:  Hannah C Evans; Caroline M Perry; Diana Faulds
Journal:  Drugs       Date:  2004       Impact factor: 9.546

4.  Factor v leiden and inflammation.

Authors:  Silvia Perez-Pujol; Omer Aras; Gines Escolar
Journal:  Thrombosis       Date:  2012-05-14

5.  Existing data sources for clinical epidemiology: The Danish Knee Arthroplasty Register.

Authors:  Alma B Pedersen; Frank Mehnert; Anders Odgaard; Henrik M Schrøder
Journal:  Clin Epidemiol       Date:  2012-05-07       Impact factor: 4.790

6.  Transcriptome analysis of Klf15‑mediated inhibitory functions in a mouse deep venous thrombosis model.

Authors:  Jin Zhou; Xueling Zhao; Shiwei Xie; Rudan Zhou
Journal:  Int J Mol Med       Date:  2020-03-13       Impact factor: 4.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.